Criterion for inclusion in onchocerciasis control programmes based on ivermectin distribution.
Identifieur interne : 012E24 ( Main/Exploration ); précédent : 012E23; suivant : 012E25Criterion for inclusion in onchocerciasis control programmes based on ivermectin distribution.
Auteurs : G. De SoleSource :
- Transactions of the Royal Society of Tropical Medicine and Hygiene [ 0035-9203 ]
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Facteurs de risque, Femelle, Humains, Ivermectine (usage thérapeutique), Mâle, Nourrisson, Nouveau-né, Onchocercose (), Onchocercose oculaire (), Prurit (), Services de santé communautaires, Sujet âgé, Sujet âgé de 80 ans ou plus, Sélection de patients, Éléphantiasis ().
- MESH :
- usage thérapeutique : Ivermectine.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Facteurs de risque, Femelle, Humains, Mâle, Nourrisson, Nouveau-né, Onchocercose, Onchocercose oculaire, Prurit, Services de santé communautaires, Sujet âgé, Sujet âgé de 80 ans ou plus, Sélection de patients, Éléphantiasis.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Community Health Services, Elephantiasis (complications), Female, Humans, Infant, Infant, Newborn, Ivermectin (therapeutic use), Male, Middle Aged, Onchocerciasis (complications), Onchocerciasis, Ocular (prevention & control), Patient Selection, Pruritus (complications), Risk Factors.
- MESH :
- chemical , therapeutic use : Ivermectin.
- complications : Elephantiasis, Onchocerciasis, Pruritus.
- prevention & control : Onchocerciasis, Ocular.
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Community Health Services, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Patient Selection, Risk Factors.
Abstract
Data on onchocercal lymphatic and skin lesions from 45 communities located in the West African savanna were analysed to determine if the criterion for inclusion in ivermectin mass treatment based on risk of onchocercal blindness needs to be modified. Only 16 cases of elephantiasis were reported among 10,108 people examined. Other lymphatic lesions were almost exclusively found in people older than 30 years living in villages at risk of onchocercal blindness. Permanent skin lesions also affected older people and were 3 times more frequent in villages at risk of onchocercal blindness. Papular rash and pruritus affected younger people. No evidence was, therefore, found to change the criterion based on risk of onchocercal blindness presently in use in savanna areas.
PubMed: 7778156
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 005422
- to stream PubMed, to step Curation: 005422
- to stream PubMed, to step Checkpoint: 005422
- to stream Ncbi, to step Merge: 00B227
- to stream Ncbi, to step Curation: 00B227
- to stream Ncbi, to step Checkpoint: 00B227
- to stream Main, to step Merge: 014043
- to stream Main, to step Curation: 012E24
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Criterion for inclusion in onchocerciasis control programmes based on ivermectin distribution.</title><author><name sortKey="De Sole, G" sort="De Sole, G" uniqKey="De Sole G" first="G" last="De Sole">G. De Sole</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>1995 Mar-Apr</MedlineDate></PubDate></date><idno type="RBID">pubmed:7778156</idno><idno type="pmid">7778156</idno><idno type="wicri:Area/PubMed/Corpus">005422</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005422</idno><idno type="wicri:Area/PubMed/Curation">005422</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005422</idno><idno type="wicri:Area/PubMed/Checkpoint">005422</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005422</idno><idno type="wicri:Area/Ncbi/Merge">00B227</idno><idno type="wicri:Area/Ncbi/Curation">00B227</idno><idno type="wicri:Area/Ncbi/Checkpoint">00B227</idno><idno type="wicri:doubleKey">0035-9203::De Sole G:criterion:for:inclusion</idno><idno type="wicri:Area/Main/Merge">014043</idno><idno type="wicri:Area/Main/Curation">012E24</idno><idno type="wicri:Area/Main/Exploration">012E24</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Criterion for inclusion in onchocerciasis control programmes based on ivermectin distribution.</title><author><name sortKey="De Sole, G" sort="De Sole, G" uniqKey="De Sole G" first="G" last="De Sole">G. De Sole</name></author></analytic><series><title level="j">Transactions of the Royal Society of Tropical Medicine and Hygiene</title><idno type="ISSN">0035-9203</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>Child, Preschool</term><term>Community Health Services</term><term>Elephantiasis (complications)</term><term>Female</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Ivermectin (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Onchocerciasis (complications)</term><term>Onchocerciasis, Ocular (prevention & control)</term><term>Patient Selection</term><term>Pruritus (complications)</term><term>Risk Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Ivermectine (usage thérapeutique)</term><term>Mâle</term><term>Nourrisson</term><term>Nouveau-né</term><term>Onchocercose ()</term><term>Onchocercose oculaire ()</term><term>Prurit ()</term><term>Services de santé communautaires</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Sélection de patients</term><term>Éléphantiasis ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Ivermectin</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Elephantiasis</term><term>Onchocerciasis</term><term>Pruritus</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Onchocerciasis, Ocular</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Ivermectine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>Child, Preschool</term><term>Community Health Services</term><term>Female</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Male</term><term>Middle Aged</term><term>Patient Selection</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Nourrisson</term><term>Nouveau-né</term><term>Onchocercose</term><term>Onchocercose oculaire</term><term>Prurit</term><term>Services de santé communautaires</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Sélection de patients</term><term>Éléphantiasis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Data on onchocercal lymphatic and skin lesions from 45 communities located in the West African savanna were analysed to determine if the criterion for inclusion in ivermectin mass treatment based on risk of onchocercal blindness needs to be modified. Only 16 cases of elephantiasis were reported among 10,108 people examined. Other lymphatic lesions were almost exclusively found in people older than 30 years living in villages at risk of onchocercal blindness. Permanent skin lesions also affected older people and were 3 times more frequent in villages at risk of onchocercal blindness. Papular rash and pruritus affected younger people. No evidence was, therefore, found to change the criterion based on risk of onchocercal blindness presently in use in savanna areas.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="De Sole, G" sort="De Sole, G" uniqKey="De Sole G" first="G" last="De Sole">G. De Sole</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 012E24 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 012E24 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:7778156
|texte= Criterion for inclusion in onchocerciasis control programmes based on ivermectin distribution.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:7778156" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |